Public-registry site landscape for NCT07724340, a Adults With Overweight/Obesity and Type 2 Diabetes study sponsored by Antag Therapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07724340 (registry record) |
| Sponsor | Antag Therapeutics |
| Condition(s) | Adults With Overweight/Obesity and Type 2 Diabetes |
| Phase | PHASE2 |
| Listed sites | 8 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT07724340 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →